The invention provides Neuregulin or a functional fragment thereof for use in a method of preventing, treating or delaying a cardiac disease or disorder in a mammal, wherein the method comprises releasing Neuregulin to the mammal by extended release means. The means used for extended release may be a polymer, e.g. PEG, liposome, microsphere, syringe or osmotic pump.